Who invested in Ribon Therapeutics?
Ribon Therapeutics's investors include Google Ventures, U.S. Venture Partners, Deerfield, Osage University Partners and AbbVie, and 5 more on record.

United States · Venture startup
Funding summaryUpdated 26 Oct 2026
$90Mraised across 2 rounds since 2018, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by MarketwatchSEC filing: $20M sold, first sale Oct 2017
From the SEC filings it signed: 3 on the team.
On the board, as filediCameron WheelerEmma ReeveEyal LifschitzJames AudiaJeff GoaterJodie MorrisonJonathan RootLaura Brass
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Ribon Therapeutics's investors include Google Ventures, U.S. Venture Partners, Deerfield, Osage University Partners and AbbVie, and 5 more on record.
Ribon Therapeutics has raised $90M across 2 rounds since 2018.
Ribon Therapeutics's most recent round was a Venture of $25M in Dec 2022.
Ribon Therapeutics's largest round on record is $65M (Series B), in Jan 2018.
Ribon Therapeutics's first round on record, in Jan 2018, was backed by U.S. Venture Partners, Deerfield and Osage University Partners and 5 others.
Ribon Therapeutics's latest named round is a Venture, in Dec 2022.
Ribon Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.